IP Library › Granted Patent US 11,491,133
Granted Patent B2
US 11,491,133 · App. 16/991,771 · Granted Nov 8, 2022

Heteroaryl-isochroman compounds and uses thereof

Inventors: Carrie A. Bowen (Uxbridge, MA); Douglas F. Burdi (Arlington, MA); Michele L. R. Heffernan (Holliston, MA); Lee W. Herman (Natick, MA); Linghong Xie (Southborough, MA)
Assignees: Sunovion Pharmaceuticals Inc.; PGI Drug Discovery LLC
A61K31/352A61K31/4155A61K31/4178A61K31/42A61K31/427A61K31/443A61K31/4433A61K31/497A61K31/506A61P25/08A61P25/16A61P25/24A61P25/28C07D405/04C07D413/04C07D417/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,491,133
App. No.
16/991,771
Granted
Nov 8, 2022
Kind
B2
Abstract

Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.

Claims (498)

1. A method for treating a neurological or psychiatric disorder in a subject, comprising administering to said subject in need thereof an effective amount of a compound of formula

or a pharmaceutically acceptable salt thereof,

wherein:

R 1 , R 2 , R 3 and R 4 are chosen independently from H and aliphatic (C 1 -C 8 )hydrocarbon, wherein the aliphatic (C 1 -C 8 )hydrocarbon is optionally substituted with one or more substituents selected from halogen, hydroxyl, (C 1 -C 6 )alkoxy, amino, (C 1 -C 6 )alkylamino and di(C 1 -C 6 )alkylamino;

or, taken together, R 1 and R 2 form (C 3 -C 6 )cycloalkyl;

R 5 and R 6 are chosen independently from H, halogen, (C 1 -C 6 )alkyl and (C 1 -C 6 )haloalkyl;

R 9 and R 10 are chosen independently from H, halogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl and (C 1 -C 6 )alkoxy;

one of R 11 , R 12 , R 13 , and R 14 is optionally substituted benzyl, optionally substituted aryl, or optionally substituted heteroaryl; and the remaining three are H; and

wherein said benzyl, aryl, and heteroaryl are each optionally substituted with one or more substituents selected from halogen, (C 1 -C 4 )alkyl, cyano, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, aminocarbonyl, (C 1 -C 6 )alkylaminocarbonyl, di(C 1 -C 6 )alkylaminocarbonyl, (C 1 -C 4 )acyl, (C 1 -C 4 )haloalkoxy, hydroxy(C 1 -C 4 )alkyl, carboxy, (C 1 -C 4 )alkoxycarbonyl, acetoxy, nitro, amino, (C 1 -C 4 )alkylamino, and di(C 1 -C 4 )alkylamino,

wherein the neurological or psychiatric disorder is depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, or epilepsy.

2. The method according to claim 1 , wherein the neurological or psychiatric disorder is depression.

3. The method according to claim 2 , wherein the depression is treatment-resistant depression (TRD), major depressive disorder (MDD), unipolar depression, bipolar depression or depression associated with another disease or disorder.

4. The method according to claim 1 , wherein the neurological or psychiatric disorder is epilepsy.

5. A method for treating a neurological or psychiatric disorder in a subject, comprising administering to said subject in need thereof an effective amount of a compound which is:

wherein the neurological or psychiatric disorder is depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, or epilepsy.

6. The method according to claim 5 , wherein the neurological or psychiatric disorder is epilepsy.

7. A method for treating a neurological or psychiatric disorder in a subject, comprising administering to said subject in need thereof an effective amount of a compound which is:

wherein the neurological or psychiatric disorder is depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, or epilepsy.

8. The method according to claim 7 , wherein the neurological or psychiatric disorder is epilepsy.

9. The method according to claim 1 wherein R 1 is hydrogen and R 2 is hydrogen or methyl.

10. The method according to claim 1 wherein R 1 and R 2 are both hydrogen.

11. The method according to claim 1 wherein R 3 is hydrogen and R 4 is hydrogen, methyl or ethyl.

12. The method according to claim 1 wherein R 3 and R 4 are both hydrogen.

13. The method according to claim 1 wherein R 5 and R 6 are both hydrogen.

14. The method according to claim 1 wherein R 9 and R 10 are chosen independently from H, fluoro, and methyl.

15. The method according to claim 1 wherein R 9 is chosen from H, fluoro, and methyl and R 10 is H.

16. The method according to claim 1 wherein R 11 is optionally substituted benzyl, optionally substituted aryl, or optionally substituted heteroaryl.

17. The method according to claim 1 wherein R 12 is optionally substituted benzyl, optionally substituted aryl, or optionally substituted heteroaryl.

18. The method according to claim 1 wherein R 13 is optionally substituted benzyl, optionally substituted aryl, or optionally substituted heteroaryl.

19. The method according to claim 1 wherein R 11 is optionally substituted benzyl, optionally substituted aryl, or optionally substituted heteroaryl.

20. The method according to claim 1 wherein said benzyl, aryl or heteroaryl is unsubstituted.

21. The method according to claim 1 wherein said optionally substituted aryl is phenyl, and said optionally substituted heteroaryl is nitrogen-containing heteroaryl.

22. The method according to claim 21 wherein said nitrogen-containing heteroaryl is selected from pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyrazolyl, imidazolyl and pyrrolyl.

23. The method according to claim 21 wherein said nitrogen-containing heteroaryl is pyridinyl.

24. The method according to claim 23 wherein said pyridinyl is at the R 11 , R 12 or R 13 position.

25. The method according to claim 1 , wherein the compound has Formula IIa:

26. The method according to claim 1 , wherein the compound has Formula IIb:

27. The method according to claim 1 wherein R 1 is hydrogen; R 2 is hydrogen or methyl; R 3 is hydrogen; R 4 is hydrogen or methyl; R 5 is hydrogen; and R 6 is hydrogen.

28. The method according to claim 27 wherein R 9 and R 10 are each independently hydrogen, fluoro, or methyl.

29. The method according to claim 28 wherein all of R 1 , R 2 , R 3 , R 5 , R 6 , R 9 and R 1- ° are hydrogen, and R 4 is hydrogen or methyl.

30. The method according to claim 29 wherein all of R 1 , R 2 , R 3 , R 5 , R 6 , R 9 , R 10 and R 14 are hydrogen; R 4 is hydrogen or methyl; and one of R 11 , R 12 , or R 13 is pyridinyl, and the remaining two are H.

31. The method according to claim 30 , wherein R 11 is pyridinyl.

32. The method according to claim 30 , wherein R 12 is pyridinyl.

33. The method according to claim 30 , wherein R 12 is 3-pyridinyl.

34. The method according to claim 30 , wherein R 13 is pyridinyl.

35. The method according to claim 30 , wherein R 13 is 3-pyridinyl or 4-pyridinyl.

36. The method according to claim 25 wherein all of R 1 , R 2 , R 3 , R 5 , R 6 , R 9 and R 10 are hydrogen, and R 4 is hydrogen or methyl.

37. The method according to claim 36 wherein one of R 11 , R 12 , or R 13 is pyridinyl, and the remaining two are H.

38. The method according to claim 26 wherein all of R 1 , R 2 , R 3 , R 5 , R 6 , R 9 and R 10 are hydrogen; and R 4 is hydrogen or methyl.

39. The method according to claim 38 wherein R 4 is hydrogen.

40. The method according to claim 1 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

41. The method according to claim 40 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

42. The method according to claim 40 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

43. The method according to claim 40 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

44. The method according to claim 40 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

45. The method according to claim 1 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

46. The method according to claim 45 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

47. The method according to claim 45 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

48. The method according to claim 45 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

49. The method according to claim 45 wherein the compound is:

or a pharmaceutically acceptable salt thereof.

50. The method according to claim 1 , wherein the compound is selected from:

Compound

Structure

No.

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

or a pharmaceutically acceptable salt thereof.

51. The method according to claim 1 , wherein the compound is selected from:

Compound No

Chemical name

1

(R)-N-Methyl-1-(8-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

2

(S)-N-Methyl-1-(8-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

3

(R)-N-Methyl-1-(7-(pyridin-3-yl)isochroman-1-yl)methanamine dihydrochloride

4

(S)-N-methyl-1-(7-(pyridin-3-yl)isochroman-1-yl)methanamine dihydrochloride

5

(R)-N-Methyl(6-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

6

(S)-N-methyl(6-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

7

(R)-N-Methyl(5-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

8

(S)-N-Methyl(5-(pyridin-3-yl)isochroman-1-yl)methanamine bis-hydrochloride

9

(R)-(8-(Pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

10

(S)-(8-(Pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

11

(R)-(7-(pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

12

(S)-(7-(pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

13

(R)-tert-Butyl (6-(pyridin-3-yl)isochroman-1-yl)methylcarbamate hydrochloride

14

(S)-tert-Butyl (6-(pyridin-3-yl)isochroman-1-yl)methylcarbamate hydrochloride

15

(R)-(5-(Pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

16

(S)-(5-(Pyridin-3-yl)isochroman-1-yl)methanamine hydrochloride

17

(R)-N-Methyl(5-(pyridin-4-yl)isochroman-1-yl)methanamine dihydrochloride

18

(S)-N-Methyl(5-(pyridin-4-yl)isochroman-1-yl)methanamine dihydrochloride

19

(R)-(5-(Pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

20

(S)-(5-(Pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

21

(R)-N-Methyl-1-(6-(pyrimidin-2-yl)isochroman-1-yl)methanamine hydrochloride

22

(S)-N-Methyl-1-(6-(pyrimidin-2-yl)isochroman-1-yl)methanamine hydrochloride

23

(S)-N-Methyl-1-(5-(pyrimidin-2-yl)isochroman-1-yl)methanamine hydrochloride

24

(R)-N-Methyl-1-(5-(pyrimidin-2-yl)isochroman-1-yl)methanamine hydrochloride

25

(S)-N-Methyl-1-(7-(pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

26

(R)-N-Methyl-1-(7-(pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

27

(R)-(5-(Pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

28

(S)-(5-(Pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

29

(R)-N-Methyl-1-(5-(pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

30

(S)-N-Methyl-1-(5-(pyrimidin-5-yl)isochroman-1-yl)methanamine hydrochloride

31

(R)-N-Methyl-1-(6-(pyridazin-3-yl)isochroman-1-yl)methanamine hydrochloride

32

(S)-N-Methyl-1-(6-(pyridazin-3-yl)isochroman-1-yl)methanamine hydrochloride

43

(R)-N-Methyl-1-(5-(pyridin-2-yl)isochroman-1-yl)methanamine hydrochloride

44

(S)-N-Methyl-1-(5-(pyridin-2-yl)isochroman-1-yl)methanamine hydrochloride

45

(R)-(5-(pyridin-2-yl)isochroman-1-yl)methanamine hydrochloride

46

(S)-(5-(pyridin-2-yl)isochroman-1-yl)methanamine hydrochloride

47

(R)-(7-(pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

48

(S)-(7-(pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

49

(R)-N-Methyl-1-(7-(pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

50

(S)-N-Methyl-1-(7-(pyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

51

N-((5-(pyridin-4-yl)isochroman-1-yl)methyl)ethanamine

52

N-Methyl-1-(5-(thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

53

N-Methyl-1-(5-(pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

54

N-Methyl-1-(5-(pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

55

N-Methyl-1-(5-(pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

56

N-Methyl-1-(5-(pyrazin-2-yl)isochroman-1-yl)methanamine hydrochloride

57

7-(Pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

58

N-Methyl-1-(7-(pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

59

(5-(Thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

60

(5-(Pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

61

(5-(Pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

62

(5-(Pyridazin-3-yl)isochroman-1-yl)methanaminehydrochloride

63

(5-(Pyrazin-2-yl)isochroman-1-yl)methanamine hydrochloride

64

(5-(Isoxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

65

1-(5-(Isoxazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

66

(R)-N-((5-(Pyridin-4-yl) isochroman-1-yl)methyl)ethanamine hydrochloride

67

(S)-N-((5-(Pyridin-4-yl) isochroman-1-yl)methyl)ethanamine hydrochloride

68

(R)-N-Methyl-1-(5-(thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

69

(S)-N-Methyl-1-(5-(thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

70

(R)-(5-(Thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

71

(S)-(5-(Thiazol-5-yl)isochroman-1-yl)methanamine hydrochloride

72

(R)-N-Methyl-1-(5-(pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

73

(S)-N-Methyl-1-(5-(pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

74

(R)-(5-(Pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

75

(S)-(5-(Pyrimidin-4-yl)isochroman-1-yl)methanamine hydrochloride

76

(R)-N-Methyl-1-(5-(pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

77

(S)-N-Methyl-1-(5-(pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

78

(R)-(5-(Pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

79

(S)-(5-(Pyridazin-4-yl)isochroman-1-yl)methanamine hydrochloride

80

(R)-N-Methyl-1-(5-(pyrazine-2-yl)isochroman-1-yl)methanamine

81

(S)-N-Methyl-1-(5-(pyrazine-2-yl)isochroman-1-yl)methanamine

82

(R)-(5-(Pyrazin-2-yl)isochroman-1-yl)methanamine hydrochloride

83

(S)-(5-(Pyrazin-2-yl)isochroman-1-yl)methanamine hydrochloride

84

(R)-1-(5-(Isoxazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

85

(S)-1-(5-(Isoxazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

86

(R)-(5-(Isoxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

87

(S)-(5-(Isoxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

88

(R)-(5-(Isoxazol-3-yl)isochroman-1-yl)methanamine hydrochloride

89

(S)-(5-(Isoxazol-3-yl)isochroman-1-yl)methanamine hydrochloride

90

(R)-1-(5-(Isoxazol-3-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

91

(S)-1-(5-(Isoxazol-3-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

92

(R)-(5-(Isoxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

93

(S)-(5-(Isoxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

94

(R)-1-(5-(Isoxazol-5-yl)isochroman-1-yl)-N-methylmethanamine

95

(S)-1-(5-(Isoxazol-5-yl)isochroman-1-yl)-N-methylmethanamine

96

(R)-N-Methyl-1-(5-(oxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

97

(S)-N-Methyl-1-(5-(oxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

98

(R)-(5-(Oxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

99

(S)-(5-(Oxazol-5-yl)isochroman-1-yl)methanamine hydrochloride

100

(R)-(5-(oxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

101

(S)-(5-(oxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

102

(R)-N-methyl-1-(5-(oxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

103

(S)-N-methyl-1-(5-(oxazol-4-yl)isochroman-1-yl)methanamine hydrochloride

104

(R)-N-Methyl-1-(5-(oxazol-2-yl)isochroman-1-yl)methanamine hydrochloride

105

(S)-N-methyl-1-(5-(oxazol-2-yl)isochroman-1-yl)methanamine dihydrochloride

106

(R)-(5-(Oxazol-2-yl)isochroman-1-yl)methanamine hydrochloride

107

(S)-(5-(Oxazol-2-yl)isochroman-1-yl)methanamine hydrochloride

108

(R)-(5-(1H-Imidazol-2-yl)isochroman-1-yl)methanamine hydrochloride

109

(S)-(5-(1H-Imidazol-2-yl)isochroman-1-yl)methanamine hydrochloride

110

(R)-1-(5-(1H-Imidazol-2-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

111

(S)-1-(5-(1H-Imidazol-2-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

112

(R)-(5-(1H-Imidazol-4-yl)isochroman-1-yl)methanamine hydrochloride

113

(S)-(5-(1H-Imidazol-4-yl)isochroman-1-yl)methanamine hydrochloride

114

(R)-1-(5-(1H-imidazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

115

(S)-1-(5-(1H-imidazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

116

(R)-(5-(1H-pyrazol-4-yl)isochroman-1-yl)methanamine hydrochloride

117

(S)-(5-(1H-pyrazol-4-yl)isochroman-1-yl)methanamine hydrochloride

118

(R)-1-(5-(1H-pyrazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

119

(S)-1-(5-(1H-pyrazol-4-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

120

(R)-N-Methyl-1-(5-(2-methylpyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

121

(S)-N-Methyl-1-(5-(2-methylpyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

122

(R)-(5-(2-Methylpyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

123

(S)-(5-(2-Methylpyridin-4-yl)isochroman-1-yl)methanamine hydrochloride

124

(R)-1-(5-(2,6-dimethylpyridin-4-yl)isochroman-1-yl)-N-methylmethanamine dihydrochloride

125

(S)-1-(5-(2,6-dimethylpyridin-4-yl)isochroman-1-yl)-N-methylmethanamine dihydrochloride

126

(R)-1-(5-(2,6-dimethylpyridin-4-yl)isochroman-1-yl)-N-methylmethanamine dihydrochloride

127

(S)-1-(5-(2,6-dimethylpyridin-4-yl)isochroman-1-yl)-N-methylmethanamine dihydrochloride

128

(R)-N-Methyl-1-(5-phenylisochroman-1-yl)methanamine hydrochloride

129

(S)-N-Methyl-1-(5-phenylisochroman-1-yl)methanamine hydrochloride

130

(R)-(5-Phenylisochroman-1-yl)methanamine hydrochloride

131

(S)-(5-Phenylisochroman-1-yl)methanamine hydrochloride

180

(R)-N-((5-(Pyridin-4-yl)isochroman-1-yl)methyl)cyclopropanamine hydrochloride

181

(S)-N-((5-(Pyridin-4-yl)isochroman-1-yl)methyl)cyclopropanamine hydrochloride

182

(R)-1-(5-(1H-Imidazol-1-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

183

(S)-1-(5-(1H-Imidazol-1-yl)isochroman-1-yl)-N-methylmethanamine hydrochloride

184

(R)-(5-(1H-Imidazol-1-yl)isochroman-1-yl)methanamine hydrochloride

185

(S)-(5-(1H-Imidazol-1-yl)isochroman-1-yl)methanamine hydrochloride

186

(R)-1-(5-(1H-pyrazol-1-yl)isochroman-1-yL)-N-methylmethanamine

187

(S)-1-(5-(1H-pyrazol-1-yl)isochroman-1-yl)-N-methylmethanamine

188

(R)-(5-(1H-pyrazol-1-yl)isochroman-1-yl)methanamine hydrochloride

189

(S)-(5-(1H-pyrazol-1-yl)isochroman-1-yl)methanamine hydrochloride

190

(R)-1-(5-(4H-1,2,4-triazol-4-yl)isochroman-1-yl)-N-methylmethanamine

191

(S)-1-(5-(4H-1,2,4-triazol-4-yl)isochroman-1-yl)-N-methylmethanamine

192

(R)-(5-(4H-1,2,4-triazol-4-yl)isochroman-1-yl)methanamine

193

(S)-(5-(4H-1,2,4-triazol-4-yl)isochroman-1-yl)methanamine

194

(R)-N,N-dimethyl-1-(5-(pyridin-4-yl)isochroman-1-yl)methanamine, and

195

(S)-N,N-dimethyl-1-(5-(pyridin-4-yl)isochroman-1-yl)methanamine,

or a pharmaceutically acceptable salt thereof.

52. The method according to claim 46 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

53. The method according to claim 52 , wherein the compound is greater than 95% enantiomerically pure.

54. The method according to claim 52 , wherein the compound is greater than 99% enantiomerically pure.

55. The method according to claim 46 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

56. The method according to claim 55 , wherein the compound is greater than 95% enantiomerically pure.

57. The method according to claim 55 , wherein the compound is greater than 99% enantiomerically pure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2020
From: SUNOVION PHARMACEUTICALS INC.
To: SUNOVION PHARMACEUTICALS INC.; PGI DRUG DISCOVERY LLC
Reel/Frame 053623/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2020
From: BOWEN, CARRIE A.; BURDI, DOUGLAS F.; HEFFERNAN, MICHELE L.R.; HERMAN, LEE W.; XIE, LINGHONG
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 053623/0465 →
Continuity (3)
Division 16051863 · Aug 1, 2018
Provisional Application 62540249 · Aug 2, 2017
Related Publication 20210093606A1 · Apr 1, 2021